Paratus Clinical Research and Waitemata Clinical Research have formed a strategic partnership to strengthen clinical trial delivery across Australia and New Zealand.
Paratus brings its centralised trial functions and national network. Waitemata brings its investigator-led research site in Auckland. Together they will give sponsors coordinated, high-quality trial delivery across the region, with streamlined start-up and consistent oversight in both countries.
“This partnership represents an important step in Paratus' expansion into New Zealand.”
Rachel Harris, founding Director of Waitemata Clinical Research, said Waitemata was pleased to join the Paratus network of high-quality, agile research sites.
Media enquiries: Heenal Patel, Head of Strategic Partnerships, Paratus Clinical. heenal.patel@paratusclinical.com
